Action of human group IIa secreted phospholipase A2 on cell membranes. Vesicle but not heparinoid binding determines rate of fatty acid release by exogenously added enzyme.

Human group IIa phospholipase A2 (hIIa-PLA2) is a highly basic protein that is secreted from a number of cells during inflammation and may play a role in arachidonate liberation and in destruction of invading bacteria. It has been proposed that rodent group IIa PLA2 is anchored to cell surfaces via attachment to heparan sulfate proteoglycan and that this interaction facilitates lipolysis. hIIa-PLA2 contains 13 lysines, 2 histidines, and 10 arginines that fall into 10 clusters. A panel of 26 hIIa-PLA2 mutants were prepared in which 1-4 basic residues in each cluster were changed to glutamate or aspartate (charge reversal). A detailed analysis of the affinities of these mutants for anionic vesicles and for heparin and heparan sulfate in vitro and of the specific activities of these proteins for hydrolysis of vesicles in vitro and of living cell membranes reveal the following trends: 1) the affinity of hIIa-PLA2 for heparin and heparan sulfate is modulated not by a highly localized site of basic residues but by diffuse sites that partially overlap with the interfacial binding site. In contrast, only those residues on the interfacial binding site of hIIa-PLA2 are involved in binding to membranes; 2) the relative ability of these mutants to hydrolyze cellular phospholipids when enzymes were added exogenously to CHO-K1, NIH-3T3, and RAW 264.7 cells correlates with their relative in vitro affinity for vesicles and not with their affinity for heparin and heparan sulfate. 3) The rates of exogenous hIIa-PLA2-catalyzed fatty acid release from wild type CHO-K1 cells and two mutant lines, one lacking glycosaminoglycan and one lacking heparan sulfate, were similar. Thus basic residues that modulate interfacial binding are important for plasma membrane fatty acid release by exogenously added hIIa-PLA2. Binding of hIIa-PLA2 to cell surface heparan sulfate does not modulate plasma membrane phospholipid hydrolysis by exogenously added hIIa-PLA2.

[1]  M. Murakami,et al.  Participation in cellular prostaglandin synthesis of type-II phospholipase A2 secreted and anchored on cell-surface heparan sulfate proteoglycan. , 1993, European journal of biochemistry.

[2]  M. Gelb,et al.  Mapping the interfacial binding surface of human secretory group IIa phospholipase A2. , 1997, Biochemistry.

[3]  D. Wilton,et al.  Comparison of the catalytic properties of phospholipase A2 from pancreas and venom using a continuous fluorescence displacement assay. , 1991, The Biochemical journal.

[4]  W. Cho,et al.  Inhibition of human secretory class II phospholipase A2 by heparin. , 1994, European journal of biochemistry.

[5]  M. Murakami,et al.  Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2. , 1993, The Journal of biological chemistry.

[6]  M. Gelb,et al.  Interfacial recognition by bee venom phospholipase A2: insights into nonelectrostatic molecular determinants by charge reversal mutagenesis. , 1998, Biochemistry.

[7]  J. Balsinde,et al.  Distinct Roles in Signal Transduction for Each of the Phospholipase A Enzymes Present in P388D Macrophages (*) , 1996, The Journal of Biological Chemistry.

[8]  P. Sigler,et al.  Structural Aspects of Interfacial Adsorption , 1997, The Journal of Biological Chemistry.

[9]  M. Murakami,et al.  Type II Secretory Phospholipase A2 Associated with Cell Surfaces via C-terminal Heparin-binding Lysine Residues Augments Stimulus-initiated Delayed Prostaglandin Generation* , 1996, The Journal of Biological Chemistry.

[10]  Mahendra K. Jain,et al.  Dehydration of the lipid-protein microinterface on binding of phospholipase A2 to lipid bilayers. , 1987, Biochimica et biophysica acta.

[11]  J. Hirsh,et al.  Heparin Binding Proteins Contribution to Heparin Rebound After Cardiopulmonary Bypass , 1993, Circulation.

[12]  W G Hol,et al.  Structure of porcine pancreatic phospholipase A2 at 2.6 A resolution and comparison with bovine phospholipase A2. , 1983, Journal of molecular biology.

[13]  J. Browning,et al.  Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes. , 1993, Journal of lipid mediators.

[14]  P. Sigler,et al.  Structure and catalytic mechanism of secretory phospholipases A2. , 1994, Advances in protein chemistry.

[15]  R. Kramer,et al.  Structure and properties of a human non-pancreatic phospholipase A2. , 1989, The Journal of biological chemistry.

[16]  O. Berg,et al.  Interfacial enzymology of glycerolipid hydrolases: lessons from secreted phospholipases A2. , 1995, Annual review of biochemistry.

[17]  M. Waite.  The Phospholipases , 1987, Handbook of Lipid Research.

[18]  S. Baker,et al.  Gossypol modification of Ala-1 of secreted phospholipase A2: a probe for the kinetic effects of sulfate glycoconjugates. , 1997, Biochemistry.

[19]  J. Massagué,et al.  A single mutation affects both N-acetylglucosaminyltransferase and glucuronosyltransferase activities in a Chinese hamster ovary cell mutant defective in heparan sulfate biosynthesis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Balsinde,et al.  Novel Group V Phospholipase A2 Involved in Arachidonic Acid Mobilization in Murine P388D1 Macrophages* , 1996, The Journal of Biological Chemistry.

[21]  M. Gelb,et al.  Interfacial catalysis: the mechanism of phospholipase A2 , 1990, Science.

[22]  M. Jain,et al.  Interfacial catalysis by phospholipase A2: monomeric enzyme is fully catalytically active at the bilayer interface. , 1991, Biochemistry.

[23]  M. Gelb,et al.  Docking phospholipase A2 on membranes using electrostatic potential-modulated spin relaxation magnetic resonance. , 1998, Science.

[24]  Mahendra K. Jain,et al.  Interaction of phospholipase A2 and phospholipid bilayers. , 1982, Biochimica et biophysica acta.

[25]  M. Hayden,et al.  Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase. , 1994, Journal of lipid research.

[26]  M. Gelb,et al.  Human nonpancreatic secreted phospholipase A2: interfacial parameters, substrate specificities, and competitive inhibitors. , 1993, Biochemistry.

[27]  J. Esko,et al.  Animal cell mutants defective in glycosaminoglycan biosynthesis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Elsbach,et al.  The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. , 1993, Immunobiology.

[29]  M. Gelb,et al.  Continuous, vesicle-based fluorimetric assays of 14- and 85-kDa phospholipases A2. , 1995, Analytical biochemistry.

[30]  L. Marshall,et al.  Evidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cells. , 1994, Journal of immunology.

[31]  E. Dennis,et al.  The growing phospholipase A2 superfamily of signal transduction enzymes. , 1997, Trends in biochemical sciences.

[32]  S. Nojima,et al.  Purification and characterization of phospholipase A2 released from rat platelets. , 1987, Journal of Biochemistry (Tokyo).

[33]  D. Riches,et al.  Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. , 1993, Journal of immunology.

[34]  R. Verger,et al.  Novel intestinal phospholipase A2: purification and some molecular characteristics. , 1982, Biochemistry.

[35]  R. Othman,et al.  Phospholipase D and phosphatidic acid enhance the hydrolysis of phospholipids in vesicles and in cell membranes by human secreted phospholipase A2. , 1998, Biochimica et biophysica acta.

[36]  M. Murakami,et al.  Triggering of degranulation in mast cells by exogenous type II phospholipase A2. , 1993, Journal of immunology.

[37]  D. Wilton,et al.  Enhanced hydrolysis of phosphatidylcholine by human group II non-pancreatic secreted phospholipase A2 as a result of interfacial activation by specific anions. Potential role of cholesterol sulphate. , 1995, The Biochemical journal.

[38]  L. Touqui,et al.  Expression of the type-II phospholipase A2 in alveolar macrophages. Down-regulation by an inflammatory signal. , 1995, The Journal of biological chemistry.

[39]  M. Lazdunski,et al.  Cloning, Chromosomal Mapping, and Expression of a Novel Human Secretory Phospholipase A2 * , 1997, The Journal of Biological Chemistry.

[40]  M. Pantoliano,et al.  Energetic characterization of the basic fibroblast growth factor-heparin interaction: identification of the heparin binding domain. , 1994, Biochemistry.

[41]  J. J. Rosa,et al.  Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate. , 1993, Science.

[42]  Y. Zuo,et al.  Identification of the Antithrombin III Heparin Binding Site* , 1997, The Journal of Biological Chemistry.

[43]  Y. Snitko,et al.  High specificity of human secretory class II phospholipase A2 for phosphatidic acid. , 1997, The Biochemical journal.

[44]  E. Dennis.  Diversity of group types, regulation, and function of phospholipase A2. , 1994, The Journal of biological chemistry.

[45]  J. Adams,et al.  SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock. , 1995, The Journal of pharmacology and experimental therapeutics.

[46]  P. Iverius.  Coupling of glycosaminoglycans to agarose beads (sepharose 4B). , 1971, The Biochemical journal.

[47]  D. Wilton,et al.  Cholesterol-3-sulfate enhances phospholipase A2 activity by promoting interfacial binding. , 1997, Biochemical Society transactions.

[48]  S. Reddy,et al.  Transcellular Prostaglandin Production following Mast Cell Activation Is Mediated by Proximal Secretory Phospholipase A and Distal Prostaglandin Synthase 1 (*) , 1996, The Journal of Biological Chemistry.

[49]  O. Berg,et al.  Kinetic basis for interfacial catalysis by phospholipase A2. , 1995, Methods in enzymology.

[50]  Mahendra K. Jain,et al.  Phospholipase A2 at the bilayer interface , 1991, Proteins.

[51]  M. Leppert,et al.  Three secretory phospholipase A(2) genes that map to human chromosome 1P35-36 are not mutated in individuals with attenuated adenomatous polyposis coli. , 1996, Cancer research.

[52]  M. Murakami,et al.  Monoclonal antibodies against rat platelet phospholipase A2. , 1988, Journal of biochemistry.

[53]  N. Kitamura,et al.  Structure of cDNA coding for rat platelet phospholipase A2. , 1989, Journal of biochemistry.

[54]  G. Atsumi,et al.  The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid. , 1997, Biochimica et biophysica acta.

[55]  M. Gelb,et al.  Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue , 1990, Science.

[56]  M. Murakami,et al.  Purification of rabbit platelet secretory phospholipase A2 and its characteristics. , 1989, Journal of biochemistry.

[57]  R. Othman,et al.  Human non-pancreatic (group II) secreted phospholipase A2 expressed from a synthetic gene in Escherichia coli: characterisation of N-terminal mutants. , 1996, Biochimica et biophysica acta.

[58]  Arthur M Buchberg,et al.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin -induced intestinal neoplasia , 1995, Cell.

[59]  W. Cho,et al.  A Structure-Function Study of Bovine Pancreatic Phospholipase A Using Polymerized Mixed Liposomes (*) , 1995, The Journal of Biological Chemistry.

[60]  J. Weiss,et al.  Mobilization and function of extracellular phospholipase A2 in inflammation. , 1990, Advances in experimental medicine and biology.

[61]  M. Diccianni,et al.  Inhibition of phospholipase A2 by heparin. , 1990, Biochimica et biophysica acta.